Antigen-independent BCR signals limit differentiation and survival of IgM antibody-secreting cells
Journal of Experimental Medicine · 2026
DOI: 10.1084/jem.20260390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2026. Verfasst von Ting-Ting Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Immunity and Immunotherapies, Seattle Children's Research Institute , Seattle, WA, USA. Hauptthemen laut MEDLINE: Immunoglobulin M, Cell Differentiation, Signal Transduction, Receptors, Antigen, B-Cell. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Seattle Children's Research Institute, Cell and Gene Therapy, Children's Guild Association Endowed Chair in Pediatric Immunology.
Abstract (Originalsprache)
IgM contributes to early and durable humoral immunity, yet the mechanisms governing human IgM plasma cell (PC) maturation and persistence remain unknown. Here, using an ex vivo human B cell system, we found that IgM B cell receptor (BCR) signaling restricts IgM antibody-secreting cell (ASC) differentiation and survival. Using CRISPR-mediated gene disruption and pharmacologic inhibition, we show that surface BCR and its proximal signaling components, particularly SYK, suppressed induction of IRF4 and PRDM1, thereby restraining PC differentiation. Concurrently, ligand-independent BCR signaling increased basal calcium flux and apoptosis in IgM plasmablasts. Inhibition of BCR-proximal signaling also increased PC numbers and persistence after in vivo engraftment. Leveraging this mechanistic insight, we demonstrated that SYK KO in engineered PCs (ePCs) significantly improved output and in vivo durability of IgM-cetuximab–secreting ePCs. Together, these findings reveal IgM-BCR signaling as a previously unrecognized negative regulator of human IgM PC differentiation and survival and show that inhibition of BCR-proximal pathways can improve IgM-based cellular immunotherapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Immunity and Immunotherapies, Seattle Children's Research Institute , Seattle, WA, USA.
- Department of Pediatrics, University of Washington, Seattle, WA, USA.
- Department of Immunology, University of Washington, Seattle, WA, USA.
- Department of Pharmacology, University of Washington, Seattle, WA, USA.
- Brotman-Baty Institute for Precision Medicine , Seattle, WA, USA.
ORCID-Profile: Ting-Ting Zhang, Nathan Camp, Gregory D Asher, Ameena Romani, Brock McKinney, Yu Chen, Parker Knebusch, David J Rawlings, Richard G James
Förderung
- Seattle Children's Research Institute
- Cell and Gene Therapy
- Children's Guild Association Endowed Chair in Pediatric Immunology
- Hansen Investigator in Pediatric Innovation Endowment
- Seattle Children’s Research Institute
- Children’s Guild Association Endowed Chair in Pediatric Immunology
Zitieren
APA
Zhang, T. T., Camp, N., Asher, G. D., Romani, A., McKinney, B., Chen, Y., Knebusch, P., Rawlings, D. J., & James, R. G. (2026). Antigen-independent BCR signals limit differentiation and survival of IgM antibody-secreting cells. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20260390
Vancouver
Zhang TT, Camp N, Asher GD, Romani A, McKinney B, Chen Y, et al. Antigen-independent BCR signals limit differentiation and survival of IgM antibody-secreting cells. Journal of Experimental Medicine. 2026. doi:10.1084/jem.20260390
BibTeX
@article{Zhang2026,
author = {Zhang, Ting-Ting and Camp, Nathan and Asher, Gregory D and Romani, Ameena and McKinney, Brock and Chen, Yu and Knebusch, Parker and Rawlings, David J and James, Richard G},
title = {Antigen-independent BCR signals limit differentiation and survival of IgM antibody-secreting cells},
journal = {Journal of Experimental Medicine},
year = {2026},
doi = {10.1084/jem.20260390}
}
EUVIMED